Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Sees Significant Drop in Short Interest

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) saw a significant decrease in short interest in the month of July. As of July 15th, there was short interest totaling 3,865 shares, a decrease of 82.0% from the June 30th total of 21,436 shares. Approximately 3.0% of the shares of the company are short sold. Based on an average daily trading volume, of 2,327 shares, the days-to-cover ratio is currently 1.7 days.

Insider Activity at Bitwise MARA Option Income Strategy ETF

In other news, major shareholder Orbimed Advisors Llc sold 860,123 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $45.36, for a total transaction of $39,015,179.28. Following the completion of the sale, the insider owned 219,405 shares in the company, valued at $9,952,210.80. This trade represents a 79.68% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Benjamin Hohl sold 6,018 shares of the firm’s stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of $43.80, for a total value of $263,588.40. Following the completion of the sale, the chief financial officer directly owned 51,000 shares of the company’s stock, valued at $2,233,800. This represents a 10.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,172,549 shares of company stock valued at $53,017,056 over the last quarter. 37.30% of the stock is currently owned by insiders.

Bitwise MARA Option Income Strategy ETF Price Performance

Shares of Bitwise MARA Option Income Strategy ETF stock traded up $0.04 during trading hours on Friday, reaching $14.52. The company had a trading volume of 6,810 shares, compared to its average volume of 4,912. The firm has a market cap of $1.89 million, a PE ratio of 290.40 and a beta of 2.74. Bitwise MARA Option Income Strategy ETF has a one year low of $11.99 and a one year high of $43.70. The business has a fifty day simple moving average of $16.60 and a 200 day simple moving average of $15.51.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.